| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 302,438 | 312,128 | 329,086 | 382,684 | | Cost of Revenue | 245,434 | 259,410 | 267,386 | 314,949 | | | Gross Profit | 57,004 | 52,718 | 61,700 | 67,735 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 51,934 | 50,378 | 52,051 | 53,729 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 3,866 | 4,813 | 3,978 | 4,037 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,204 | (2,473) | 5,671 | 9,969 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 88 | 22 | 55 | 2,697 | | Earnings Before Interest And Taxes | (3,381) | (2,451) | 5,726 | 12,666 | | Interest Expense | (3,131) | 1,507 | 1,624 | 4,933 | | Income Before Tax | (250) | (3,958) | 4,102 | 7,733 | | Income Tax Expense | (3,258) | (2,437) | 1,239 | 2,610 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,008 | (1,521) | 2,863 | 5,123 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,008 | (1,521) | 2,863 | 5,123 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,008 | ($1,521) | $2,863 | $5,123 |
|
0.51% Nasdaq 
Income Statement
